The Journal of Immunology, Vol 150, Issue 11 5086-5093, Copyright © 1993 by American Association of Immunologists

ARTICLES

Short time exposure to lipopolysaccharide is sufficient to activate human monocytes

P Gallay, CV Jongeneel, C Barras, M Burnier, JD Baumgartner, MP Glauser and D Heumann
Department of Internal Medicine, CHUV-Lausanne, Switzerland.

Very little is known about early events in LPS binding and about the duration of LPS exposure required to activate monocytes. In the present study, we have investigated the kinetics of LPS binding to human monocytes and the time of exposure required to trigger the synthesis of TNF-alpha. We directly followed the binding of FITC-labeled LPS to monocytes by flow cytometry or confocal laser microscopy. LPS was able to bind to the cell surface within 1 min of exposure, and was internalized within 5 min. Equilibrium was reached within 15 min at all but the lowest LPS concentration tested (10 ng/ml). Binding was dependent on the presence of LPS-binding protein, supplied either as a plasma component or in purified form, and inhibited by an anti-CD14 mAb (MY4). Polymyxin B, an inhibitor of LPS-mediated activation, essentially abrogated the LPS-binding protein- and CD14-dependent binding of LPS to monocytes. Using either the anti-CD14 mAb or polymyxin B to block further LPS binding, we found that 5 to 10 min of exposure was sufficient to trigger maximal TNF-alpha release. Similarly, monocytes washed after 5 to 15 min exposure to eliminate LPS also produced high levels of TNF-alpha transcripts without further presence of LPS in the medium. We conclude that a few minutes of exposure to physiologically relevant concentrations of LPS are sufficient to trigger both maximal binding and activation of monocytes.

This article has been cited by other articles:

				R. S. Birjmohun, S. I. van Leuven, J. H.M. Levels, C. van 't Veer, J. A. Kuivenhoven, J. C.M. Meijers, M. Levi, J. J.P. Kastelein, T. van der Poll, and E. S.G. Stroes High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in Humans Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1153 - 1158. [Abstract] [Full Text] [PDF]

				P. Ashwood, R. P. H. Thompson, and J. J. Powell Fine Particles That Adsorb Lipopolysaccharide Via Bridging Calcium Cations May Mimic Bacterial Pathogenicity Towards Cells Experimental Biology and Medicine, January 1, 2007; 232(1): 107 - 117. [Abstract] [Full Text] [PDF]

				V. Perlik, Z. Li, S. Goorha, L. R. Ballou, and C. M. Blatteis LPS-activated complement, not LPS per se, triggers the early release of PGE2 by Kupffer cells Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R332 - R339. [Abstract] [Full Text] [PDF]

				E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF]

				N. Hiki, Y. Mimura, T. Ogawa, J. Kojima, F. Hatao, and M. Kaminishi Pathophysiological relevance of the CD14 receptor in surgical patients: biological activity of endotoxin is regulated by the CD14 receptor Innate Immunity, December 1, 2001; 7(6): 461 - 466. [Abstract] [PDF]

				G. D. Kutuzova, R. M. Albrecht, C. M. Erickson, and N. Qureshi Diphosphoryl Lipid A from Rhodobacter sphaeroides Blocks the Binding and Internalization of Lipopolysaccharide in RAW 264.7 Cells J. Immunol., July 1, 2001; 167(1): 482 - 489. [Abstract] [Full Text] [PDF]

				C. Alexander and E. Th. Rietschel Invited review: Bacterial lipopolysaccharides and innate immunity Innate Immunity, June 1, 2001; 7(3): 167 - 202. [Abstract] [PDF]

				P. Borron, J. C. McIntosh, T. R. Korfhagen, J. A. Whitsett, J. Taylor, and J. R. Wright Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L840 - L847. [Abstract] [Full Text] [PDF]

				R. L. Kitchens, G. Wolfbauer, J. J. Albers, and R. S. Munford Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface J. Biol. Chem., November 26, 1999; 274(48): 34116 - 34122. [Abstract] [Full Text] [PDF]

				N. Hiki, D. Berger, M. A. Dentener, Y. Mimura, W. A. Buurman, C. Prigl, M. Seidelmann, E. Tsuji, M. Kaminishi, and H. G. Beger Changes in Endotoxin-Binding Proteins during Major Elective Surgery: Important Role for Soluble CD14 in Regulation of Biological Activity of Systemic Endotoxin Clin. Vaccine Immunol., November 1, 1999; 6(6): 844 - 850. [Abstract] [Full Text] [PDF]

				Y.-C. Chen, S.-Y. Wang, and C.-C. King Bacterial Lipopolysaccharide Inhibits Dengue Virus Infection of Primary Human Monocytes/Macrophages by Blockade of Virus Entry via a CD14-Dependent Mechanism J. Virol., April 1, 1999; 73(4): 2650 - 2657. [Abstract] [Full Text]

				C. Stamme and J. R. Wright Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages Am J Physiol Lung Cell Mol Physiol, March 1, 1999; 276(3): L540 - L547. [Abstract] [Full Text] [PDF]

				R. L. Kitchens, P.-y. Wang, and R. S. Munford Bacterial Lipopolysaccharide Can Enter Monocytes Via Two CD14-Dependent Pathways J. Immunol., November 15, 1998; 161(10): 5534 - 5545. [Abstract] [Full Text] [PDF]

				C. Poussin, M. Foti, J.-L. Carpentier, and J. Pugin CD14-dependent Endotoxin Internalization via a Macropinocytic Pathway J. Biol. Chem., August 7, 1998; 273(32): 20285 - 20291. [Abstract] [Full Text] [PDF]

				E. Sehic, S. Li, A. L. Ungar, and C. M. Blatteis Complement reduction impairs the febrile response of guinea pigs to endotoxin Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1594 - R1603. [Abstract] [Full Text] [PDF]

				M. G. Netea, N. de Bont, P. N. M. Demacker, B. J. Kullberg, L. E. H. Jacobs, T. J. G. Verver-Jansen, A. F. H. Stalenhoef, and J. W. M. Van der Meer Lipoprotein(a) Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Mononuclear Cells Infect. Immun., May 1, 1998; 66(5): 2365 - 2367. [Abstract] [Full Text] [PDF]

				L. C. Denlinger, K. A. Garis, J. A. Sommer, A. G. Guadarrama, R. A. Proctor, and P. J. Bertics Nuclear Translocation of NF-kappa B in Lipopolysaccharide-Treated Macrophages Fails To Correspond to Endotoxicity: Evidence Suggesting a Requirement for a Gamma Interferon-Like Signal Infect. Immun., April 1, 1998; 66(4): 1638 - 1647. [Abstract] [Full Text] [PDF]

				N. Hiki, D. Berger, C. Prigl, E. Boelke, H. Wiedeck, M. Seidelmann, L. Staib, M. Kaminishi, T. Oohara, and H. G. Beger Endotoxin Binding and Elimination by Monocytes: Secretion of Soluble CD14 Represents an Inducible Mechanism Counteracting Reduced Expression of Membrane CD14 in Patients with Sepsis and in a Patient with Paroxysmal Nocturnal Hemoglobinuria Infect. Immun., March 1, 1998; 66(3): 1135 - 1141. [Abstract] [Full Text] [PDF]

				R. L. Kitchens and R. S. Munford CD14-Dependent Internalization of Bacterial Lipopolysaccharide (LPS) Is Strongly Influenced by LPS Aggregation But Not by Cellular Responses to LPS J. Immunol., February 15, 1998; 160(4): 1920 - 1928. [Abstract] [Full Text] [PDF]

				D. Le Roy, M.P. Glauser, and D. Heumann LPS binding protein (LBP) function in germfree mice Innate Immunity, June 1, 1997; 4(3): 183 - 187. [Abstract] [PDF]

				M.T. Demitri, M. Velucchi, L. Bracci, A. Rustici, M. Porro, P. Villa, and P. Ghezzi Inhibition of LPS-induced systemic and local TNF production by a synthetic anti-endotoxin peptide (SAEP-2) Innate Immunity, December 1, 1996; 3(6): 445 - 454. [Abstract] [PDF]

				D. Heumann, P. Gallay, C. Barras, H. Albrecht, J.C. de Flaugergues, A. Steck, and M.P. Glauser Lipopolysaccharide binding protein (LBP) as a marker of protein leakage in cerebrospinal fluid Innate Immunity, February 1, 1995; 2(1): 1 - 7. [Abstract] [PDF]